Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Teva Pharma's Short Sellers Double Down as Legal Woes Drag On - BNN Bloomberg
Teva CEO to Meet Netanyahu With Blunt Message on Need for Cuts - Bloomberg
Activist Investor Jana Partners Takes Stake in Teva, Report Says | Ctech
Teva (TEVA) Agrees to $225 Million Texas Opioid Settlement, AG Says - Bloomberg
A bottle of Teva Pharmaceutical Industries Ltd. Clonazepam medication... News Photo - Getty Images
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Teva plans to raise Mylan bid by as much as $2 billion: Bloomberg | Reuters
Teva Sees Adderall Supply Delays Continuing for 2-3 Months (1)
Teva Is 'on the Way' to Leaving Opioid Litigation Behind, CEO Says | Barron's
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Tags search | Ctech
The Difficulties of Cloning a CEO - Bloomberg
Teva Plunges as U.S. Sales Drop Amid Generic Price Erosion - Bloomberg
Teva Analysts Say Migraine Drug Approval Gives Needed Relief - Bloomberg
Drugmaker Teva makes $40B bid for rival Mylan
Teva Pharma's Short Sellers Double Down as Legal Woes Drag On - Bloomberg
Teva CEO Resigns; Dividend Cut Should Be Next - Bloomberg
Adderall Shortages Spread to 4 Pharmaceutical Companies Including Teva, Novartis - Bloomberg
Teva's Credit Rating Cut to Junk by Fitch - Bloomberg
Teva flags supply constraints to ADHD drug Adderall as demand rises (NYSE: TEVA) | Seeking Alpha
ADHD Drug Adderall Supply Delays Likely to Continue for 2-3 Months, Teva Says - Bloomberg
Actavis CEO: Teva-Mylan deal could be "value-destroying" - גלובס
Teva looks to sell generics in China through joint venture with Guangzhou Pharma: Bloomberg | Fierce Pharma
Sandoz, Amneal and Rhodes join Teva in nationwide generic Adderall shortage as demand spikes
Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement - Bloomberg
Future Teva CEO Seeks to 'Formulate Clear Strategy' - YouTube
Teva Loses CEO, Leaving Investors to Guess What's Next - Bloomberg
